IL140164A0 - Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug - Google Patents

Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Info

Publication number: IL140164A0
Authority: IL; Israel
Prior art keywords: carnitine; drug; containing composition; dietary supplement; composition useful
Prior art date: 1999-04-22

Application number

IL14016400A

Other languages

English (en)

Original Assignee

Sigma Tau Healthscience Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-22

Filing date

2000-04-19

Publication date

2002-02-10

2000-04-19 Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa

2002-02-10 Publication of IL140164A0 publication Critical patent/IL140164A0/xx

Links

PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title 1
INAPMGSXUVUWAF-GCVPSNMTSA-N [(2r,3s,5r,6r)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate Chemical compound OC1[C@H](O)[C@@H](O)C(OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-GCVPSNMTSA-N 0.000 title 1
229960004203 carnitine Drugs 0.000 title 1
235000015872 dietary supplement Nutrition 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Biochemistry (AREA)
Orthopedic Medicine & Surgery (AREA)
Nutrition Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)

IL14016400A 1999-04-22 2000-04-19 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug IL140164A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT1999RM000248A IT1306133B1 (it)	1999-04-22	1999-04-22	Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
PCT/IT2000/000158 WO2000064426A2 (en)	1999-04-22	2000-04-19	Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Publications (1)

Publication Number	Publication Date
IL140164A0 true IL140164A0 (en)	2002-02-10

Family

ID=11406708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14016400A IL140164A0 (en)	1999-04-22	2000-04-19	Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Country Status (26)

Country	Link
US (1)	US6565876B1 (de)
EP (1)	EP1119363B1 (de)
JP (1)	JP2002542282A (de)
KR (1)	KR20010053023A (de)
CN (1)	CN1359295A (de)
AR (1)	AR023391A1 (de)
AT (1)	ATE299370T1 (de)
AU (1)	AU776591B2 (de)
BR (1)	BR0006076A (de)
CA (1)	CA2335015C (de)
DE (1)	DE60021247T2 (de)
DK (1)	DK1119363T3 (de)
EE (1)	EE200000742A (de)
ES (1)	ES2243254T3 (de)
HU (1)	HU227357B1 (de)
IL (1)	IL140164A0 (de)
IS (1)	IS5763A (de)
IT (1)	IT1306133B1 (de)
NO (1)	NO20006429L (de)
PL (1)	PL197885B1 (de)
PT (1)	PT1119363E (de)
SI (1)	SI1119363T1 (de)
SK (1)	SK19322000A3 (de)
TN (1)	TNSN00083A1 (de)
TR (1)	TR200003737T1 (de)
WO (1)	WO2000064426A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1316997B1 (it) *	2000-03-02	2003-05-26	Sigma Tau Healthscience Spa	Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) *	2000-07-06	2017-10-12	Beiersdorf Ag	Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) *	2001-06-19	2003-01-09	Beiersdorf Ag	Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) *	2003-07-25	2012-05-08	University Of Massachusetts	Formulations for reducing neuronal degeneration
US20090169585A1 (en) *	2003-10-23	2009-07-02	Resveratrol Partners, Llc	Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) *	2004-04-19	2005-10-20	Schreiber Brian D	Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
WO2006102060A1 (en) *	2005-03-18	2006-09-28	Oxyplus, Inc.	Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
ES2280136B1 (es) *	2006-02-17	2008-08-16	Universitat De Les Illes Balears	Asociacion a dosis fija de fitato y zinc.
JP5281268B2 (ja) *	2007-10-31	2013-09-04	花王株式会社	筋力向上剤
US8597640B2 (en) *	2007-10-31	2013-12-03	University Of Massachusetts Lowell	Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
JP2012508267A (ja) *	2008-11-11	2012-04-05	シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ	セルライトの処置に有用な化合物
EP2582368B1 (de) *	2010-06-16	2018-05-09	Alfasigma S.p.A.	Acetyl-L-carnitin zur Erhöhung der Neurogenese in neuronalem Gewebe
ES2495666B1 (es) *	2013-03-15	2015-08-10	Laboratoris Sanifit, S.L.	Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) *	2018-11-12	2020-08-06	주식회사 노암	항암용 조성물
TW202110437A (zh) *	2019-05-23	2021-03-16	美商希諾瓦有限責任公司	用於酒精誘發之皮膚潮紅之治療及緩解的組成物及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5626849A (en) *	1995-06-07	1997-05-06	Reliv International, Inc.	Weight loss composition for burning and reducing synthesis of fats
EP1021177A4 (de) *	1997-02-04	2002-05-15	John V Kosbab	Zusammensetzungen und verfahren zur verhütung und behandlung von vaskulär-degeneratieve krankheiten
IT1291113B1 (it) *	1997-03-20	1998-12-29	Sigma Tau Ind Farmaceuti	Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) *	1997-11-04	1999-05-18	Oncologics, Inc.	Green nutritional powder composition

1999
- 1999-04-22 IT IT1999RM000248A patent/IT1306133B1/it active
2000
- 2000-04-05 AR ARP000101562A patent/AR023391A1/es unknown
- 2000-04-19 TR TR2000/03737T patent/TR200003737T1/xx unknown
- 2000-04-19 JP JP2000613417A patent/JP2002542282A/ja active Pending
- 2000-04-19 SI SI200030711T patent/SI1119363T1/xx unknown
- 2000-04-19 EP EP00922866A patent/EP1119363B1/de not_active Expired - Lifetime
- 2000-04-19 WO PCT/IT2000/000158 patent/WO2000064426A2/en not_active Ceased
- 2000-04-19 HU HU0102926A patent/HU227357B1/hu not_active IP Right Cessation
- 2000-04-19 EE EEP200000742A patent/EE200000742A/xx unknown
- 2000-04-19 PT PT00922866T patent/PT1119363E/pt unknown
- 2000-04-19 DE DE60021247T patent/DE60021247T2/de not_active Expired - Lifetime
- 2000-04-19 DK DK00922866T patent/DK1119363T3/da active
- 2000-04-19 KR KR1020007014435A patent/KR20010053023A/ko not_active Withdrawn
- 2000-04-19 CA CA002335015A patent/CA2335015C/en not_active Expired - Lifetime
- 2000-04-19 PL PL346160A patent/PL197885B1/pl unknown
- 2000-04-19 SK SK1932-2000A patent/SK19322000A3/sk unknown
- 2000-04-19 AT AT00922866T patent/ATE299370T1/de active
- 2000-04-19 IL IL14016400A patent/IL140164A0/xx unknown
- 2000-04-19 BR BR0006076-3A patent/BR0006076A/pt not_active Application Discontinuation
- 2000-04-19 ES ES00922866T patent/ES2243254T3/es not_active Expired - Lifetime
- 2000-04-19 CN CN00800654A patent/CN1359295A/zh active Pending
- 2000-04-19 AU AU43135/00A patent/AU776591B2/en not_active Ceased
- 2000-04-19 US US09/720,099 patent/US6565876B1/en not_active Expired - Lifetime
- 2000-04-20 TN TNTNSN00083A patent/TNSN00083A1/fr unknown
- 2000-12-08 IS IS5763A patent/IS5763A/is unknown
- 2000-12-15 NO NO20006429A patent/NO20006429L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US6565876B1 (en)	2003-05-20
AR023391A1 (es)	2002-09-04
SI1119363T1 (en)	2005-10-31
CA2335015A1 (en)	2000-11-02
NO20006429L (no)	2001-02-20
BR0006076A (pt)	2001-03-20
AU776591B2 (en)	2004-09-16
JP2002542282A (ja)	2002-12-10
ATE299370T1 (de)	2005-07-15
DE60021247T2 (de)	2006-04-27
PL197885B1 (pl)	2008-05-30
ES2243254T3 (es)	2005-12-01
HUP0102926A2 (hu)	2002-03-28
EE200000742A (et)	2002-04-15
IT1306133B1 (it)	2001-05-30
EP1119363A2 (de)	2001-08-01
HUP0102926A3 (en)	2002-12-28
SK19322000A3 (sk)	2001-06-11
ITRM990248A1 (it)	2000-10-22
KR20010053023A (ko)	2001-06-25
DE60021247D1 (de)	2005-08-18
NO20006429D0 (no)	2000-12-15
IS5763A (is)	2000-12-08
DK1119363T3 (da)	2005-10-17
AU4313500A (en)	2000-11-10
TNSN00083A1 (fr)	2005-11-10
EP1119363B1 (de)	2005-07-13
TR200003737T1 (tr)	2001-07-23
PT1119363E (pt)	2005-09-30
WO2000064426A2 (en)	2000-11-02
CN1359295A (zh)	2002-07-17
CA2335015C (en)	2008-03-18
PL346160A1 (en)	2002-01-28
WO2000064426A3 (en)	2001-05-25
HU227357B1 (en)	2011-04-28

Publication	Publication Date	Title
GB9916536D0 (en)	1999-09-15	Nutritional or pharmaceutical compositions
EG24066A (en)	2008-05-08	Novel quinuclidine derivatives and medicinal compositions containing the same
IL144977A0 (en)	2002-06-30	Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
HUP0203378A3 (en)	2004-07-28	Pharmaceutical compounds and pharmaceutical compositions containing them
IL138899A0 (en)	2001-11-25	Amidene derivatives and pharmaceutical compositions containing the same
IL140862A (en)	2005-05-17	Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
HUP0201409A2 (en)	2002-08-28	Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
IL143920A0 (en)	2002-04-21	3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
HUP0302492A3 (en)	2005-05-30	Methods and compositions for the prevention of tolerance to medications
IL164022A0 (en)	2005-12-18	Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same
PL343627A1 (en)	2001-08-27	Medicinal compositions
HUP0101381A3 (en)	2002-06-28	Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP0102926A3 (en)	2002-12-28	Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
HUP0202788A3 (en)	2003-02-28	Indolyl-3-glyoxylic acid derivatives serving as antitumor agents and pharmaceutical compositions containing them
EP1166786A4 (de)	2004-05-12	Medizinische zusammenssetzungen
IL147214A0 (en)	2002-08-14	1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0105204A3 (en)	2002-05-28	Substituted phenethylamine derivatives and pharmaceutical compositions containing them
HUP0200747A3 (en)	2003-02-28	Pharmaceutical compounds and pharmaceutical compositions containing them
IL148807A0 (en)	2002-09-12	Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
HUP0200055A3 (en)	2002-10-28	16-hydroxyestrienes and pharmaceutical compositions containing the same
HUP0200468A3 (en)	2002-12-28	Resorcinol derivatives and pharmaceutical compositions containing them
GB2354153B (en)	2002-10-16	Dietary supplement
HUP0000042A3 (en)	2001-07-30	Omega-3-fatacid and vitamin containing meet product
GB9820815D0 (en)	1998-11-18	Improvementsin or relating to nutritional and pharmaceutical compositions
GB9920054D0 (en)	1999-10-27	Dietary composition